In this regard, impaired TGF-β signaling has been demonstrated to contribute to AD neurodegeneration through several mechanisms including microglial activation, cell-cycle reactivation, and increased levels of secreted Aβ (Das and Golde, 2006; Tesseur et al., 2006). Here, TGFB1 is linked to Alzheimer disease.